{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:12:14Z","timestamp":1790039534824,"version":"4.0.1"},"reference-count":20,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1506,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1751-7176.2011.00507.x","type":"journal-article","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T12:41:32Z","timestamp":1310992892000},"page":"690-692","source":"Crossref","is-referenced-by-count":43,"title":["Direct-Acting Vasodilators"],"prefix":"10.1111","volume":"13","author":[{"given":"Jay N.","family":"Cohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon T.","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,18]]},"reference":[{"issue":"3","key":"10.1111\/j.1751-7176.2011.00507.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00005344-198605000-00014","article-title":"Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects","volume":"8","author":"Shepherd","year":"1986","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1111\/j.1751-7176.2011.00507.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.3.5.580","article-title":"Plasma concentration and acetylator phenotype determine response to oral hydralazine","volume":"3","author":"Shepherd","year":"1981","journal-title":"Hypertension"},{"issue":"5 Pt 1","key":"10.1111\/j.1751-7176.2011.00507.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cpt1975185part1581","article-title":"Duration of hydralazine action in hypertension","volume":"18","author":"O\u2019Malley","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB4|cit4","first-page":"1107","article-title":"Hydralazine once daily in hypertension","volume":"36","author":"Riska","year":"1984","journal-title":"Curr Ther Res"},{"issue":"20","key":"10.1111\/j.1751-7176.2011.00507.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB6|cit6","first-page":"845","article-title":"Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype","volume":"65","author":"Russell","year":"1987","journal-title":"Q J Med"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0002-9149(77)80029-5","article-title":"Effect of minoxidil on blood pressure and haemodynamics in severe hypertension","volume":"39","author":"Bryan","year":"1977","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0773.1992.tb00466.x","article-title":"Clinical pharmacology of potassium channel openers","volume":"70","author":"Andersson","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3565(25)24105-2","article-title":"Mechanism of action of minoxidil sulphate-induced vasodilatation: a role for increased K+ permeability","volume":"245","author":"Meisheri","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl 2","key":"10.1111\/j.1751-7176.2011.00507.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/00005344-198000022-00002","article-title":"Pharmacology and pharmacokinetics of minoxidil","volume":"2","author":"Lowenthal","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(82)92162-6","article-title":"Treatment of refractory hypertension","volume":"1","author":"Swales","year":"1982","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.2.6134.385","article-title":"Need for beta blockade in hypertension reduced with long-term minoxidil","volume":"2","author":"Brunner","year":"1978","journal-title":"BMJ"},{"issue":"suppl 2","key":"10.1111\/j.1751-7176.2011.00507.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1097\/00005344-198000022-00014","article-title":"Serial electrocardiographic changes during long-term treatment of severe hypertension with minoxidil","volume":"2","author":"Hall","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/clpt.1981.128","article-title":"Minoxidil and pericardial effusion: an idiosyncratic reaction","volume":"30","author":"Reichgott","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3565(25)32738-2","article-title":"Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates","volume":"218","author":"Ignarro","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM197409192911201","article-title":"Treatment of refractory heart failure with infusion of nitroprusside","volume":"291","author":"Guiha","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.7326\/0003-4819-91-5-752","article-title":"Diagnosis and treatment - drugs five years later: nitroprusside","volume":"91","author":"Cohn","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/clpt.1986.137","article-title":"Transdermal nitroglycerin as a step 3 antihypertensive drug","volume":"40","author":"Simon","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1111\/j.1751-7176.2011.00507.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1524-6175.2005.04141.x","article-title":"Why don\u2019t we use nitrates to treat older hypertensive patients?","volume":"7","author":"Pickering","year":"2005","journal-title":"J Clin Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00507.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0735-1097(95)00368-1","article-title":"Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure","volume":"26","author":"Gogia","year":"1995","journal-title":"J Am Coll Cardiol"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7176.2011.00507.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:02:58Z","timestamp":1741320178000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7176.2011.00507.x"}},"subtitle":["Direct-Acting Vasodilators"],"short-title":[],"issued":{"date-parts":[[2011,7,18]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00507.x","relation":{},"ISSN":["1524-6175"],"issn-type":[{"value":"1524-6175","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,18]]}}}